Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10026612 | The Journal of Molecular Diagnostics | 2005 | 4 Pages |
Abstract
Chronic granulomatous disease (CGD) is a rare inherited disorder in which antimicrobial activity of phagocytes is impaired due to the lack of reactive oxygen species, or oxidative burst, produced by NADPH oxidase. The X-linked form of CGD, representing â¼70% of all cases, is caused by mutations in the cytochrome b β subunit (CYBB) gene, which maps to chromosome Xp21.1. CYBB encodes the gp91-phox protein, a necessary component in the NADPH oxidase pathway. A wide variety of mutations have been identified in X-linked CGD patients, all of which lead to deletion of the functional protein and no oxidative burst activity. The mutations vary from single nucleotide substitutions to deletions of the entire gene. In this article, we report a mutation detection method for probands of female relatives at risk for carrier status of large deletions of the CYBB gene. Through fluorescent in situ hybridization of metaphase chromosomes, we were able to consistently distinguish carriers from noncarriers using polymerase chain reaction-derived, labeled DNA specific for exons 2 to 13 of the CYBB region at Xp21.1.
Related Topics
Health Sciences
Medicine and Dentistry
Health Informatics
Authors
Kelly Claire Simon, Deborah Noack, Julie Rae, John Curnutte, Shireen Sarraf, Valentin Kolev, Jan K. Blancato,